GTRx, a clinical decision support tool, can provide front-line clinicians with the information they need to initiate precision treatments for critically ill infants and children in intensive care Rady Children’s Institute for Genomic Medicine (RCIGM®) today announced the publication of a study in Nature Communications describing and examining the performance of Genome-to-Treatment (GTRx™), an automated, virtual disease management system that integrates a rapid Whole Genome Sequencing (rWGS®) diagnosis completed in 13.5 hours with a custom lab information management system and analysis pipeline. Currently, GTRx is a prototype and encompasses about 500 genetic diseases that progress rapidly and have effective, available …